GT Biopharma (GTBP) Q2 2026 Earnings

15MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.83
-0.59
-0.35
-0.11

Details

Expected EPS
-0.11
Actual EPS
-0.11
Surprise EPS
0
Surprise Percent
+0%

Description

GT Biopharma (GTBP) has reported earnings of -0.11 per share for Q2 2026.

0 Comments

Share your thoughts